Crossmark

https://doi.org/10.1016/j.abdp.2020.08.020

Crossref DOI link: https://doi.org/10.1016/j.abdp.2020.08.020

Published Print: 2000

Update policy: https://doi.org/10.1016/elsevier_cm_policy

License Information

Text and Data Mining valid from 2000-01-01

Text and Data Mining valid from 2000-01-01

Version of Record valid from 2021-09-29
More Information

This article is maintained by: Elsevier

Article Title: Segurança e eficácia de 104 semanas de dupilumabe no tratamento de dermatite atópica grave. A experiência de cinco unidades dermatológicas de referência na Espanha

Journal Title: Anais Brasileiros de Dermatologia (Versão em Português)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abdp.2020.08.020

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.abd.2020.08.030

Content Type: article

Copyright: © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.